This bill revises Massachusetts law governing price and network-status disclosures for health care services. It requires a health care provider, when scheduling a non-emergency admission, procedure, or service, or upon request, to tell a patient whether the provider participates in the patient’s health benefit plan. For ongoing courses of treatment, the provider does not need to repeat the disclosure for each subsequent service if the initial disclosure was documented, but must notify the patient if participation status changes.
The bill also creates a more detailed cost-estimate process. If the provider is in-network, the provider must send the patient’s health insurance carrier a good-faith estimate of expected billing and diagnostic codes, and the carrier must return an estimate of the patient’s expected out-of-pocket responsibility within specified timeframes. If the provider is out-of-network, or if the patient is uninsured or not using insurance, the provider must give the patient relevant cost information, including a good-faith estimate of charges and any facility fees, and must explain that the patient may be able to obtain the service at lower cost from an in-network provider. The bill allows providers to satisfy these requirements by complying with federal notice rules under the No Surprises Act framework.
The bill’s impact on state law is to replace existing Section 228 of Chapter 111 with a streamlined disclosure regime that aligns state requirements more closely with federal patient cost-estimate rules. It also limits billing consequences for out-of-network providers who fail to give the required notices: they may not bill insured patients beyond the copayment, coinsurance, or deductible that would have applied in-network. The Department of Public Health is given enforcement authority, with civil penalties capped at $2,500 per violation for both providers and carriers, subject to exceptions where the same violation has already been penalized by CMS or, for carriers, by the Massachusetts Division of Insurance.
Because there is no recorded committee transcript or vote history provided, there is no direct evidence of debate or formal support/opposition in the available record. Based on the bill text alone, the measure appears aimed at consumer transparency and administrative simplification, suggesting a generally pro-patient and pro-disclosure policy approach. The title and structure indicate an effort to reduce duplicative notices while preserving access to pricing information.
The main points of potential contention are likely to be the compliance burden on providers and insurers, the short deadlines for producing estimates, and the enforcement penalties. Providers may view the bill as adding operational requirements, especially for out-of-network or uninsured patients, while patient advocates would likely favor the clearer cost information and billing protections. The bill also raises coordination questions between state enforcement and existing federal No Surprises Act requirements, particularly where compliance can be achieved through federal notice rules.
The bill amends Chapter 111, section 228 of the Massachusetts General Laws by replacing the current patient disclosure requirements with a more detailed framework for network-status notices and cost estimates. It affects health care providers, health insurance carriers, uninsured patients, and insured patients receiving scheduled non-emergency care. It also authorizes the commissioner to enforce the section and impose civil penalties, while limiting state penalties where the same violation has already been penalized federally or by another state regulator.
No committee transcripts or votes are available, so there is no recorded legislative debate to summarize. The bill’s text suggests a generally favorable policy posture toward patient transparency, simplified disclosures, and clearer billing expectations. Its structure indicates an attempt to align state law with federal disclosure rules rather than create a wholly new system.
The likely areas of contention are administrative burden, timing, and enforcement. Health care providers may object to the obligation to provide network-status disclosures, good-faith estimates, and facility-fee information on short timelines, while insurers may be concerned about the carrier-side estimate deadlines and compliance costs. Patient advocates are likely to support the measure because it improves price transparency and limits surprise billing, but providers may be concerned about the restriction on billing when required notices are not provided and the $2,500 per-instance penalty structure.